Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Pediatric Highlight
  • Published:

Pancreatic polypeptide in obese children before and after weight loss

Abstract

Objective:

Little is known concerning pancreatic polypeptide (PP) in weight loss and in childhood obesity.

Methods:

Fasting PP, leptin and insulin concentrations were determined in 38 obese children and compared with 35 lean children of the same age, gender and pubertal stage. Furthermore, changes of PP concentrations over a 1-year period were analyzed in the obese children participating in a weight loss intervention program.

Results:

Obese children had significantly (P<0.01) lower PP, and higher leptin and insulin levels compared to lean children. In multiple linear regression analysis, PP was significantly negatively correlated to body mass index (P<0.01), but not to leptin, insulin, age, gender and pubertal stage. Changes of PP did not significantly correlate to changes of insulin (r=0.07, P=0.343) and leptin (r=−0.02, P=0.459). The substantial weight loss in 17 children led to a significant (P<0.05) increase in PP and decrease in insulin and leptin. In the 21 children without substantial weight loss, there were no significant changes in PP, insulin and leptin.

Conclusions:

PP concentrations are decreased in obese children and independent of age, gender, pubertal stage, leptin and insulin. The decrease of PP in obese children normalized after weight loss. Therefore, low PP concentrations reflect the overweight status, rather than cause it.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Wynne K, Stanley S, McGowan B, Bloom S . Appetite control. J Endocrinol 2005; 184: 291–318.

    Article  CAS  PubMed  Google Scholar 

  2. Wynne K, Stanley S, Bloom S . The gut and regulation of body weight. J Clin Endocrinol Metab 2004; 89: 2576–2582.

    Article  CAS  PubMed  Google Scholar 

  3. Murphy KG, Bloom SR . Gut hormones in the control of appetite. Exp Physiol 2004; 89: 507–516.

    Article  CAS  PubMed  Google Scholar 

  4. Small CJ, Bloom SR . Gut hormones and the control of appetite. Trends Endocrinol Metab 2004; 15: 259–263.

    Article  CAS  PubMed  Google Scholar 

  5. Schwartz TW . Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983; 85: 1411–1425.

    CAS  PubMed  Google Scholar 

  6. Weyer C, Salbe AD, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA . Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans? Metabolism 2001; 50: 223–230.

    Article  CAS  PubMed  Google Scholar 

  7. Vozarova de Courten B, Weyer C, Stefan N, Horton M, DelParigi A, Havel P et al. Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians. Diabetes 2004; 53: 663–671.

    Article  CAS  PubMed  Google Scholar 

  8. Katsuura G, Asakawa A, Inui A . Roles of pancreatic polypeptide in regulation of food intake. Peptides 2002; 23: 323–329.

    Article  CAS  PubMed  Google Scholar 

  9. Asawaka A, Inui A, Ueno N, Fujino MA, Kasuga M . Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptide 1999; 20: 1445–1448.

    Article  Google Scholar 

  10. Gettys TW, Garcia R, Savage K, Whitcomb DC, Kanayama S, Taylor IL . Insulin-sparing effects of pancreatic polypeptide in congenitally obese rodents. Pancreas 1991; 6: 46–53.

    Article  CAS  PubMed  Google Scholar 

  11. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003; 124: 1325–1336.

    Article  CAS  PubMed  Google Scholar 

  12. Ueno N, Inui A, Iwamoto M, Kaga T, Asakawa A, Okita M et al. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 1999; 117: 1427–1432.

    Article  CAS  PubMed  Google Scholar 

  13. Brunicardi FC, Chaiken RL, Ryan AS, Seymour NE, Hoffmann JA, Lebovitz HE et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996; 81: 3566–3572.

    CAS  PubMed  Google Scholar 

  14. Batterham RL, Le Roux CW, Cohen MA, Park A, Ellis SM, Patterson M et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 2003; 88: 3989–3992.

    Article  CAS  PubMed  Google Scholar 

  15. Hazelwood RL . The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavorial implications. Proc Soc Exp Biol Med 1993; 202: 44–63.

    Article  CAS  PubMed  Google Scholar 

  16. Wisen O, Bjorvell H, Cantor P, Johansson C, Theodorsson E . Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal. Regul Pept 1992; 39: 43–54.

    Article  CAS  PubMed  Google Scholar 

  17. Pieramico O, Malfertheiner P, Nelson DK, Glasbrenner B, Ditschuneit H . Interdigestive cycling and post-prandial release of pancreatic polypeptide in severe obesity. Int J Obes Relat Metab Disord 1990; 14: 1005–1011.

    CAS  Google Scholar 

  18. Meryn S, Stein D, Straus EW . Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation. Int J Obes Relat Metab Disord 1986; 10: 37–42.

    CAS  Google Scholar 

  19. Lassmann V, Vague P, Vialettes B, Simon MC . Low plasma levels of pancreatic polypeptide in obesity. Diabetes 1980; 29: 428–430.

    Article  CAS  PubMed  Google Scholar 

  20. Glaser B, Zoghlin G, Pienta K, Vinik AI . Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance. Horm Metab Res 1988; 20: 288–292.

    Article  CAS  PubMed  Google Scholar 

  21. Marco J, Zulueta MA, Correas I, Villanueva ML . Reduced pancreatic polypeptide secretion in obese subjects. J Clin Endocrinol Metab 1980; 50: 744–747.

    Article  CAS  PubMed  Google Scholar 

  22. Meryn S, Stein D, Straus EW . Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity. Metabolism 1986; 35: 798–802.

    Article  CAS  PubMed  Google Scholar 

  23. Schrumpf E, Linnestad P, Nygaard K, Giercksky KE, Fausa O . Pancreatic polypeptide secretion before and after gastric bypass surgery for morbid obesity. Scand J Gastroenterol 1981; 16: 1009–1014.

    Article  CAS  PubMed  Google Scholar 

  24. Miskowiak J, Andersen B, Stadil F, Fahrenkrug J . Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity. Regul Pept 1985; 12: 231–236.

    Article  CAS  PubMed  Google Scholar 

  25. Druce MR, Small CJ, Bloom SR . Minireview: Gut peptides regulating satiety. Endocrinology 2004; 145: 2660–2665.

    Article  CAS  PubMed  Google Scholar 

  26. Reinehr T, Brylak K, Alexy U, Kersting M, Andler W . Predictors to success in outpatient training in obese children and adolescents. Int J Obes Relat Metab Disord 2003; 27: 1087–1092.

    Article  CAS  PubMed  Google Scholar 

  27. Reinehr T, Kersting M, Alexy U, Andler W . Long-term follow-up of overweight children: after training, after a single consultation session and without treatment. J Pediatr Gastroenterol Nutr 2003; 37: 72–74.

    Article  PubMed  Google Scholar 

  28. Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiß HC, Hesse V et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001; 149: 807–818.

    Article  Google Scholar 

  29. Cole TJ . The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45–60.

    CAS  PubMed  Google Scholar 

  30. Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol 1988; 60: 709–723.

    CAS  PubMed  Google Scholar 

  31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  CAS  PubMed  Google Scholar 

  32. Reinehr T, Kiess W, Kapellen T, Andler W . Insulin sensitivity in obese children and adolescents according to degree of weight loss. Pediatrics 2004; 114: 1569–1573.

    Article  PubMed  Google Scholar 

  33. Reinehr T, Andler W . Changes in the atherogenic risk-factor profile according to degree of reduction of overweight. Arch Dis Child 2004; 89: 419–422.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Koska J, Delparigi A, de Courten B, Weyer C, Tataranni PA . Pancreatic polypeptide is involved in the regulation of body weight in Pima Indian male subjects. Diabetes 2004; 53: 3091–3096.

    Article  CAS  PubMed  Google Scholar 

  35. Drent ML, Popp-Snijders C, Ader HJ, Jansen JB, van der Veen EA . Lipase inhibition and hormonal status, body composition and gastrointestinal processing of a liquid high-fat mixed meal in moderately obese subjects. Obes Res 1995; 3: 573–581.

    Article  CAS  PubMed  Google Scholar 

  36. Floyd JC . Human pancreatic polypeptide. J Clin Endocrinol Metab 1979; 8: 379–399.

    Article  CAS  Google Scholar 

  37. Hansen BC, Jen KL, Pek SB, Wolfe RA . Fluctuations in basal plasma levels of pancreatic polypeptide in monkeys and humans. Am J Physiol 1985; 248: R739–R747.

    CAS  PubMed  Google Scholar 

  38. Holst JJ, Schwartz TW, Lovgreen NA, Pedersen O, Beck-Nielsen H . Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. Int J Obes Relat Metab Disord 1983; 7: 529–538.

    CAS  Google Scholar 

  39. Lieverse RJ, Masclee AA, Jansen JB, Lamers CB . Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons. Int J Obes Relat Metab Disord 1994; 18: 123–127.

    CAS  PubMed  Google Scholar 

  40. Wallace TM, Matthews DR . The assessment of insulin resistance in man. Diabetes Med 2002; 19: 527–534.

    Article  CAS  Google Scholar 

  41. Sichert-Hellert W, Kersting M, Schöch G . Underreporting of energy intake in 1 to 18 year old German children and adolescents. Z Ernährungswiss 1998; 37: 242–251.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank R Maslak, Children's Hospital University of Bonn, for her kind support in the laboratory. This work has been supported by the Bonfor Research Foundation, University of Bonn, Germany and by NIH RR0163 and DK 62202.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Reinehr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reinehr, T., Enriori, P., Harz, K. et al. Pancreatic polypeptide in obese children before and after weight loss. Int J Obes 30, 1476–1481 (2006). https://doi.org/10.1038/sj.ijo.0803393

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803393

Keywords

This article is cited by

Search

Quick links